Synthesis and function of phospholipids in Staphylococcus aureus.
暂无分享,去创建一个
[1] C. Wolz,et al. Changing the phospholipid composition of Staphylococcus aureus causes distinct changes in membrane proteome and membrane‐sensory regulators , 2010, Proteomics.
[2] D. White,et al. Biosynthesis of Cardiolipin from Phosphatidylglycerol in Staphylococcus aureus , 1972, Journal of bacteriology.
[3] Phosphatidylglycerol homeostasis in glycerol-phosphate auxotrophs of Staphylococcus aureus , 2013, BMC Microbiology.
[4] Kai Simons,et al. Lipid Rafts As a Membrane-Organizing Principle , 2010, Science.
[5] Yoshikazu Hirai,et al. Alteration in phospholipid composition of Staphylococcus aureus during formation of autoplast. , 1980, Biochimica et biophysica acta.
[6] M. Kiriukhin,et al. Biosynthesis of the Glycolipid Anchor in Lipoteichoic Acid of Staphylococcus aureus RN4220: Role of YpfP, the Diglucosyldiacylglycerol Synthase , 2001, Journal of bacteriology.
[7] O. Schneewind,et al. Genes Required for Glycolipid Synthesis and Lipoteichoic Acid Anchoring in Staphylococcus aureus , 2007, Journal of bacteriology.
[8] W. Nauseef,et al. Effect of d-Alanylation of (Lipo)Teichoic Acids of Staphylococcus aureus on Host Secretory Phospholipase A2 Action before and after Phagocytosis by Human Neutrophils1 , 2006, The Journal of Immunology.
[9] A. Cheung,et al. Interaction of the GraRS Two-Component System with the VraFG ABC Transporter To Support Vancomycin-Intermediate Resistance in Staphylococcus aureus , 2007, Antimicrobial Agents and Chemotherapy.
[10] A. Peschel,et al. Molecular Basis of Resistance to Muramidase and Cationic Antimicrobial Peptide Activity of Lysozyme in Staphylococci , 2007, PLoS pathogens.
[11] M. Gelb,et al. Role of Charge Properties of Bacterial Envelope in Bactericidal Action of Human Group IIA Phospholipase A2against Staphylococcus aureus* , 2002, The Journal of Biological Chemistry.
[12] Angela M. Smith,et al. A Conserved Hydrolase Responsible for the Cleavage of Aminoacylphosphatidylglycerol in the Membrane of Enterococcus faecium , 2013, The Journal of Biological Chemistry.
[13] O. Schneewind,et al. Synthesis of glycerol phosphate lipoteichoic acid in Staphylococcus aureus , 2007, Proceedings of the National Academy of Sciences.
[14] A. Peschel,et al. Alanyl-Phosphatidylglycerol and Lysyl-Phosphatidylglycerol Are Translocated by the Same MprF Flippases and Have Similar Capacities To Protect against the Antibiotic Daptomycin in Staphylococcus aureus , 2012, Antimicrobial Agents and Chemotherapy.
[15] T. Goldmann,et al. Multiple Peptide Resistance Factor (MprF)-mediated Resistance of Staphylococcus aureus against Antimicrobial Peptides Coincides with a Modulated Peptide Interaction with Artificial Membranes Comprising Lysyl-Phosphatidylglycerol* , 2011, The Journal of Biological Chemistry.
[16] C. Rock,et al. Analysis of the Staphylococcus aureus DgkB structure reveals a common catalytic mechanism for the soluble diacylglycerol kinases. , 2008, Structure.
[18] U. Houtsmuller,et al. ON THE ACCUMULATION OF AMINO ACID DERIVATIVES OF PHOSPHATIDYLGLYCEROL IN BACTERIA. , 1964, Biochimica et biophysica acta.
[19] M. Débarbouillé,et al. Investigation of the Staphylococcus aureus GraSR Regulon Reveals Novel Links to Virulence, Stress Response and Cell Wall Signal Transduction Pathways , 2011, PloS one.
[20] R. Stabler,et al. Staphylococcal Phenotypes Induced by Naturally Occurring and Synthetic Membrane-Interactive Polyphenolic β-Lactam Resistance Modifiers , 2014, PloS one.
[21] D. White,et al. Metabolism of Phosphatidylglycerol, Lysylphosphatidylglycerol, and Cardiolipin of Staphylococcus aureus , 1971, Journal of Bacteriology.
[22] C. Rock,et al. Incorporation of extracellular fatty acids by a fatty acid kinase‐dependent pathway in Staphylococcus aureus , 2014, Molecular microbiology.
[23] W. Nauseef,et al. Synergy between Extracellular Group IIA Phospholipase A2 and Phagocyte NADPH Oxidase in Digestion of Phospholipids of Staphylococcus aureus Ingested by Human Neutrophils1 , 2005, The Journal of Immunology.
[24] T. Ohta,et al. Staphylococcus aureus requires cardiolipin for survival under conditions of high salinity , 2011, BMC Microbiology.
[25] A. Peschel,et al. Staphylococcus aureus evasion of innate antimicrobial defense. , 2008, Future microbiology.
[26] S. Matsuoka,et al. The Bacillus subtilis essential gene dgkB is dispensable in mutants with defective lipoteichoic acid synthesis. , 2011, Genes & genetic systems.
[27] R. Ohniwa,et al. Alternative cardiolipin synthase Cls1 compensates for stalled Cls2 function in Staphylococcus aureus under conditions of acute acid stress. , 2013, FEMS microbiology letters.
[28] A. Peschel,et al. Broad‐spectrum antimicrobial peptide resistance by MprF‐mediated aminoacylation and flipping of phospholipids , 2011, Molecular microbiology.
[29] C. Rock,et al. Bacterial lipids: metabolism and membrane homeostasis. , 2013, Progress in lipid research.
[30] Chitra Subramanian,et al. Metabolic basis for the differential susceptibility of Gram-positive pathogens to fatty acid synthesis inhibitors , 2011, Proceedings of the National Academy of Sciences.
[31] James C. Abbott,et al. c-di-AMP Is a New Second Messenger in Staphylococcus aureus with a Role in Controlling Cell Size and Envelope Stress , 2011, PLoS pathogens.
[32] Scott D. Taylor,et al. Cardiolipin Prevents Membrane Translocation and Permeabilization by Daptomycin* , 2014, The Journal of Biological Chemistry.
[33] C. Rock,et al. Identification of a two-component fatty acid kinase responsible for host fatty acid incorporation by Staphylococcus aureus , 2014, Proceedings of the National Academy of Sciences.
[34] A. Gründling,et al. Cyclic di-AMP: another second messenger enters the fray , 2013, Nature Reviews Microbiology.
[35] K. Rigby,et al. Staphylococcus aureus Mutant Screen Reveals Interaction of the Human Antimicrobial Peptide Dermcidin with Membrane Phospholipids , 2009, Antimicrobial Agents and Chemotherapy.
[36] S. Kikuchi,et al. Purification and characterization of an unusually large fatty acid synthase from Mycobacterium tuberculosis var. bovis BCG. , 1992, Archives of biochemistry and biophysics.
[37] Dongxu Sun,et al. Role in Cell Permeability of an Essential Two-Component System in Staphylococcus aureus , 1999, Journal of bacteriology.
[38] C. Rock,et al. Membrane lipid homeostasis in bacteria , 2008, Nature Reviews Microbiology.
[39] K. Kurokawa,et al. Inhibitory Effects of Basic or Neutral Phospholipid on Acidic Phospholipid-mediated Dissociation of Adenine Nucleotide Bound to DnaA Protein, the Initiator of Chromosomal DNA Replication* , 2003, Journal of Biological Chemistry.
[40] C. Rock,et al. Acyl-phosphates initiate membrane phospholipid synthesis in Gram-positive pathogens. , 2006, Molecular cell.
[41] Roy R Chaudhuri,et al. Comprehensive identification of essential Staphylococcus aureus genes using Transposon-Mediated Differential Hybridisation (TMDH) , 2009, BMC Genomics.
[42] H. Kalbacher,et al. Inactivation of the dlt Operon inStaphylococcus aureus Confers Sensitivity to Defensins, Protegrins, and Other Antimicrobial Peptides* , 1999, The Journal of Biological Chemistry.
[43] C. Weidenmaier,et al. DltABCD- and MprF-Mediated Cell Envelope Modifications of Staphylococcus aureus Confer Resistance to Platelet Microbicidal Proteins and Contribute to Virulence in a Rabbit Endocarditis Model , 2005, Infection and Immunity.
[44] K. Muchová,et al. The Role of Lipid Domains in Bacterial Cell Processes , 2013, International journal of molecular sciences.
[45] W. Fischer. Lipoteichoic acid and lipids in the membrane of Staphylococcus aureus , 1994, Medical Microbiology and Immunology.
[46] H. Hayashi,et al. Alteration of the phospholipid composition of Staphylococcus aureus cultured in medium containing NaCl. , 1972, Biochimica et biophysica acta.
[47] L. van Deenen,et al. On the amino acid esters of phosphatidyl glycerol from bacteria. , 1965, Biochimica et biophysica acta.
[48] D. Ward,et al. Whole Genome Characterization of the Mechanisms of Daptomycin Resistance in Clinical and Laboratory Derived Isolates of Staphylococcus aureus , 2012, PloS one.
[49] K. Bayles,et al. Identification of the Staphylococcus aureus vfrAB Operon, a Novel Virulence Factor Regulatory Locus , 2014, Infection and Immunity.
[50] T. Msadek,et al. GraXSR Proteins Interact with the VraFG ABC Transporter To Form a Five-Component System Required for Cationic Antimicrobial Peptide Sensing and Resistance in Staphylococcus aureus , 2011, Antimicrobial Agents and Chemotherapy.
[51] K. Yasuhiro,et al. Alteration of the phospholipid composition of Staphylo-coccus aureus cultured in medium containing NaCl , 1972 .
[52] P. Bradford,et al. Inactivation of mprF affects vancomycin susceptibility in Staphylococcus aureus. , 2003, Biochimica et biophysica acta.
[53] W. Lennarz,et al. Metabolism of Phosphatidylglycerol and Lysyl Phosphatidylglycerol in Staphylococcus aureus , 1970, Journal of bacteriology.
[54] H. Kalbacher,et al. The Bacterial Defensin Resistance Protein MprF Consists of Separable Domains for Lipid Lysinylation and Antimicrobial Peptide Repulsion , 2009, PLoS pathogens.
[55] W. Scott,et al. Effect of divalent cations on the structure of the antibiotic daptomycin , 2008, European Biophysics Journal.
[56] A. Peschel,et al. Characterization of Staphylococcus aureus Cardiolipin Synthases 1 and 2 and Their Contribution to Accumulation of Cardiolipin in Stationary Phase and within Phagocytes , 2011, Journal of bacteriology.
[57] P. Elsbach,et al. Phospholipid Synthesis by Staphylococcus aureus during (Sub)Lethal Attack by Mammalian 14-Kilodalton Group IIA Phospholipase A2 , 2000, Infection and Immunity.
[58] Roberto Kolter,et al. Functional microdomains in bacterial membranes. , 2010, Genes & development.
[59] Jeroen S. Dickschat,et al. Identification and Characterization of a Periplasmic Aminoacyl-phosphatidylglycerol Hydrolase Responsible for Pseudomonas aeruginosa Lipid Homeostasis* , 2013, The Journal of Biological Chemistry.
[60] F. Young,et al. Regulation of the Bacterial Cell Wall: Effect of Antibiotics on Lipid Biosynthesis , 1973, Antimicrobial Agents and Chemotherapy.
[61] H. Neumann,et al. MprF-mediated biosynthesis of lysylphosphatidylglycerol, an important determinant in staphylococcal defensin resistance. , 2004, FEMS microbiology letters.
[62] M. Débarbouillé,et al. Structural Basis for Feed-Forward Transcriptional Regulation of Membrane Lipid Homeostasis in Staphylococcus aureus , 2013, PLoS pathogens.
[63] R. Kariyama,et al. Lipid Composition of Staphylococcus aureus and Its Derived L‐forms , 1979, Microbiology and immunology.
[64] R. Proctor,et al. In vitro susceptibility of Staphylococcus aureus to thrombin-induced platelet microbicidal protein-1 (tPMP-1) is influenced by cell membrane phospholipid composition and asymmetry. , 2007, Microbiology.
[65] Hidemi Kurihara,et al. Staphylococcus aureus Susceptibility to Innate Antimicrobial Peptides, (cid:2) -Defensins and CAP18, Expressed by Human Keratinocytes , 2003 .
[66] B. Neumeister,et al. MprF-Mediated Lysinylation of Phospholipids in Staphylococcus aureus Leads to Protection against Oxygen-Independent Neutrophil Killing , 2003, Infection and Immunity.
[67] W. Fischer,et al. The role of lipoteichoic acid biosynthesis in membrane lipid metabolism of growing Staphylococcus aureus. , 1984, European journal of biochemistry.
[68] N. McCallum,et al. Reduced Content of Lysyl-Phosphatidylglycerol in the Cytoplasmic Membrane Affects Susceptibility to Moenomycin, as Well as Vancomycin, Gentamicin, and Antimicrobial Peptides, in Staphylococcus aureus , 2004, Antimicrobial Agents and Chemotherapy.
[69] A. Gründling,et al. Lipoteichoic acid synthesis and function in gram-positive bacteria. , 2014, Annual review of microbiology.
[70] Michael Otto,et al. Staphylococcus aureus Resistance to Human Defensins and Evasion of Neutrophil Killing via the Novel Virulence Factor Mprf Is Based on Modification of Membrane Lipids with l-Lysine , 2001, The Journal of experimental medicine.
[71] J. Schrenzel,et al. Failures in Clinical Treatment of Staphylococcus aureus Infection with Daptomycin Are Associated with Alterations in Surface Charge, Membrane Phospholipid Asymmetry, and Drug Binding , 2007, Antimicrobial Agents and Chemotherapy.